$BLRX..$.89..good idea there from BioHunter. The company has a market cap of 49m and has 41m in cash now! Their portfolio is very undervalued with solid partnerships with Merck in the area of pancreatic cancer & Immuno-Oncology. Key Milestones right around the corner with September 7-10.